Want to see AU:IME full AI Analyst Report?
IME Stock Chart & Stats
AU$0.40
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.40
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.21 - AU$0.47
Previous CloseN/A
Volume202.98K
Average Volume (3M)41.77K
Market Cap
AU$18.76M
Enterprise ValueAU$16.30M
Total Cash (Recent Filing)AU$3.30M
Total Debt (Recent Filing)AU$566.32K
Price to Earnings (P/E)―
Beta0.42
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding54,375,668
10 Day Avg. Volume23,052
30 Day Avg. Volume41,775
Financial Highlights & Ratios
PEG Ratio1.98
Price to Book (P/B)1.29
Price to Sales (P/S)0.71
P/FCF Ratio83.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.02
Revenue Forecast (FY)AU$32.59M
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue GrowthSustained acceleration in top-line growth indicates stronger product adoption or market expansion, improving the firm's ability to absorb fixed costs and leverage scale over time. If maintained, this trend supports longer-term margin recovery and provides a base for reinvestment into growth initiatives and product development.
Conservative Balance Sheet With Very Low LeverageVery low debt levels provide durable financial flexibility, lowering solvency risk and the cost of distress. This conservatism gives management room to invest in growth, pursue M&A, or weather cyclical headwinds without immediate refinancing pressure, strengthening the company's strategic optionality over months.
Turnaround To Positive Operating And Free Cash FlowRestoring positive operating and free cash flow signals that the core business can generate internal funding for working capital and limited reinvestment, reducing reliance on external capital. If cash generation stabilises, it materially improves sustainability of operations and funding for strategic priorities.
Bears Say
Persistent Net Losses And Negative Operating MarginOngoing losses and negative operating margins erode equity and limit internal capital available for investment. Persistent unprofitability pressures return metrics and forces continued dependence on external funding or equity dilution, constraining strategic initiatives and making long-term sustainable profitability an outstanding execution risk.
Sharp Gross Margin DeteriorationA pronounced drop in gross margin suggests rising delivery costs or pricing pressure that directly undermines operating leverage. Without recovery, lower gross margins compress operating profit potential, require higher revenue growth to reach breakeven, and indicate structural cost or pricing issues that management must address to restore unit economics.
Cash Flow Volatility And Inconsistent ConversionInconsistent cash conversion and volatile free cash flow make forecasting and capital allocation difficult, increasing financing uncertainty. Even with a recent positive print, irregular cash performance raises the risk that short-term cash surpluses reverse, forcing external funding or cutbacks and impeding steady investment in growth.
ImExHS Limited News
IME FAQ
What was ImExHS Limited’s price range in the past 12 months?
ImExHS Limited lowest share price was AU$0.20 and its highest was AU$0.47 in the past 12 months.
What is ImExHS Limited’s market cap?
ImExHS Limited’s market cap is AU$18.76M.
When is ImExHS Limited’s upcoming earnings report date?
ImExHS Limited’s upcoming earnings report date is Aug 31, 2026 which is in 56 days.
How were ImExHS Limited’s earnings last quarter?
ImExHS Limited released its earnings results on Feb 26, 2026. The company reported AU$0.002 earnings per share for the quarter, beating the consensus estimate of -AU$0.015 by AU$0.017.
Is ImExHS Limited overvalued?
According to Wall Street analysts ImExHS Limited’s price is currently Overvalued.
Does ImExHS Limited pay dividends?
ImExHS Limited does not currently pay dividends.
What is ImExHS Limited’s EPS estimate?
ImExHS Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ImExHS Limited have?
ImExHS Limited has 54,375,668 shares outstanding.
What happened to ImExHS Limited’s price movement after its last earnings report?
ImExHS Limited reported an EPS of AU$0.002 in its last earnings report, beating expectations of -AU$0.015. Following the earnings report the stock price went up 9.756%.
Which hedge fund is a major shareholder of ImExHS Limited?
Currently, no hedge funds are holding shares in AU:IME
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ImExHS Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.55%
12-Months-Change
Fundamentals
Return on Equity
-19.01%
Trailing 12-Months
Asset Growth
8.81%
Trailing 12-Months
Company Description
ImExHS Limited
ImExHS Limited delivers cloud-powered medical imaging technologies to customers worldwide, including those in Australia. The firm specializes in the development and sale of modular imaging software systems, which encompass comprehensive information management platforms for disciplines such as radiology, cardiology, and pathology, alongside a robust picture archiving and communication system (PACS). Its principal software solutions include AQUILA for radiology, ALULA for pathology, and Antero for cardiology. Moreover, ImExHS offers STELLA.I, a suite of artificial intelligence tools hosted in the cloud, crafted to bolster diagnostic capabilities for medical professionals. The company further extends outsourced radiology and teleradiology services to hospitals and various other healthcare entities. Established in 2001, ImExHS Limited operates from its base in Mascot, Australia.
Technical Analysis
Resonance Health Ltd
―
Beamtree Holdings Ltd
―
―
Singular Health Group Ltd
―
PainChek Ltd
―
Options Prices
Currently, No data available
---